Johnson & Johnson (ETR:JNJ)
130.22
-0.10 (-0.08%)
Jun 27, 2025, 5:35 PM CET
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€597,179
Profits / Employee
€145,800
Market Cap
314.87B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
Johnson & Johnson News
- 3 days ago - Johnson & Johnson: Undervalued Dividend King With 65% Upside Potential - Seeking Alpha
- 3 days ago - How To Build A $1,000,000 Dividend Portfolio That Could Yield 11%+ In 15 Years - Seeking Alpha
- 3 days ago - Best Dividend Kings: June 2025 - Seeking Alpha
- 4 days ago - Johnson & Johnson reports positive results from Imaavy study - Seeking Alpha
- 4 days ago - IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC) - Benzinga
- 4 days ago - IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC) - PRNewsWire
- 6 days ago - Donald Trump Jr. Joins Mark Cuban In Slamming Elizabeth Warren on Healthcare Pricing - Benzinga
- 7 days ago - Johnson & Johnson Unusual Options Activity For June 20 - Benzinga